Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 2:48 pm Sale |
2022-02-14 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 5,391,870 5.100% |
-1,625,252 (-23.16%) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
The Vanguard Group | 8,158,515 7.720% |
227,295 (+2.87%) |
Filing History |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 10,062,965 9.518% |
-1,418,606 (-12.36%) |
Filing History |
| 2022-02-01 5:08 pm Sale |
2021-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
BlackRock Inc. BLK |
9,610,871 9.100% |
-165,315 (-1.69%) |
Filing History |
| 2021-02-16 1:00 pm Sale |
2021-02-16 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 7,017,122 6.700% |
-1,334,829 (-15.98%) |
Filing History |
| 2021-02-10 11:47 am Purchase |
2020-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
The Vanguard Group | 7,931,220 7.560% |
1,678,917 (+26.85%) |
Filing History |
| 2021-02-08 10:31 am Sale |
2021-02-05 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR LLC | 11,481,571 10.949% |
-723,674 (-5.93%) |
Filing History |
| 2021-02-01 08:23 am Purchase |
2020-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
BlackRock Inc. BLK |
9,776,186 9.300% |
3,637,338 (+59.25%) |
Filing History |